Response to the comment on "Disrupted ACTH and cortisol response to osmotic and non-osmotic stress in patients with arginine vasopressin deficiency" [0.03%]
对“精氨酸血管加压素缺乏患者的渗透性及非渗透性刺激对其促肾上腺皮质激素和皮质醇反应的干扰”的评论答复
Andi Nikaj,Cihan Atila,Mirjam Christ-Crain
Andi Nikaj
Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults [0.03%]
欧洲内分泌学会临床实践指南(更新版):成人慢性低甲状旁腺素血症的治疗
Jens Bollerslev,Ottilia Buch,Luís Miguel Cardoso et al.
Jens Bollerslev et al.
In the present European Society of Endocrinology (ESE) clinical guideline, we present recommendations for the diagnosis, management, and monitoring of chronic hypoparathyroidism (HypoPT) in adults. Management of HypoPT has changed since the...
Practice Guideline
European journal of endocrinology. 2025 Oct 30;193(5):G49-G78. DOI:10.1093/ejendo/lvaf222 2025
A practical approach to diagnosis and treatment in children with Primary Adrenal Insufficiency [0.03%]
原发性肾上腺皮质功能不全患儿的诊断及治疗策略探讨
Donatella Capalbo,Sara Illiano,Sara Vasaturo et al.
Donatella Capalbo et al.
Primary adrenal insufficiency (PAI) is a rare, life-threatening condition. In children, PAI is associated with several heterogeneous conditions, both genetic and acquired, although inherited disorders are more common. The most frequent caus...
Long-term tocilizumab therapy in patients with corticosteroid-resistant active moderate-to-severe thyroid eye disease [0.03%]
托西珠单抗治疗糖皮质激素抵抗的中重度甲状腺相关性眼病患者的长期疗效
Florian Dalmas,Clémence Foing,Geneviève Darrason et al.
Florian Dalmas et al.
Objective: To evaluate the efficacy of long-term tocilizumab (TCZ) therapy in patients with corticosteroid-resistant moderate-to-severe thyroid eye disease (TED). ...
Metaphyseal Band Fractures in Pediatric Patients Treated with Denosumab [0.03%]
儿童狄诺塞麦治疗患者 metaphyseal 带状骨折案例报告
Rodrigo Montero-Lopez,Karissa Ludwig,Benjamin Jacobs et al.
Rodrigo Montero-Lopez et al.
Objective: Denosumab, a potent antiresorptive agent targeting RANKL, is increasingly used off-label in RANKL-mediated pediatric bone disorders, but concerns remain regarding rebound hypercalcaemia and altered bone modelin...
Sex dimorphic associations between oxidative stress and adiposity in early childhood [0.03%]
儿童早期氧化应激与肥胖的性别差异关联性研究
Zi-Lin Chen,Xin Liu,Min-Yi Tao et al.
Zi-Lin Chen et al.
Objective: Oxidative stress is suspected in the development of obesity. We sought to evaluate the relationship between oxidative stress and obesity/adiposity in early childhood, and explore potential sex dimorphic associa...
Agouti-Related Peptide: A Promising Prognostic Biomarker in Adrenocortical Carcinoma. Results from a Large Single-Centre Cross-Sectional Analysis [0.03%]
阿黑皮素相关肽:一种有前景的肾上腺皮质癌预后生物标志物。来自单中心大样本横断面分析的结果
Mario Detomas,Lisa R Kagan,James F H Pittaway et al.
Mario Detomas et al.
Background: Adrenocortical carcinoma (ACC) is a rare but aggressive malignancy with a heterogeneous prognosis. To date, there are no reliable circulating biomarker to predict clinical outcomes in ACC. Agouti-related pepti...
GLP-1R Agonists and Muscle Health: Potential Role in Sarcopenia Prevention and Treatment [0.03%]
GLP-1受体激动剂与肌肉健康:在抗肌少症中的潜在作用
Ainhoa González-Luis,Vicente Llinares-Arvelo,Carlos E Martínez-Alberto et al.
Ainhoa González-Luis et al.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone therapy for weight loss and glycemic control in type 2 diabetes mellitus (T2DM) and obesity. Moreover, robust cardiometabolic benefits and favorable safety p...
Epidemiological and Clinical Data from the European lipodystrophy (ECLip) registry [0.03%]
欧洲脂代谢异常注册中心的流行病学和临床资料
Giovanni Ceccarini,Camille Vatier,Baris Akinci et al.
Giovanni Ceccarini et al.
Objective: Lipodystrophy syndromes comprise a group of rare diseases characterized by loss of adipose tissue without nutritional or catabolic causes. As the rarity of these conditions necessitates collaboration, the Europ...
Chrysi Kaparounaki,Mirela-Diana Ilie,Dario De Alcubierre et al.
Chrysi Kaparounaki et al.
Objective: Acromegaly is a rare disorder caused by a growth hormone-secreting pituitary adenoma. Clinical trial evidence for its management is limited. This study compared medical treatments for acromegaly through a netwo...